These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 39107738)

  • 21. A 7-year-old boy with central diabetes insipidus presenting with thickened pituitary stalk and anti-rabphilin-3A antibody positivity.
    Morota K; Tadokoro H; Sawano K; Watanabe K; Iwata N; Fujisawa H; Suzuki A; Sugimura Y; Nagasaki K
    J Pediatr Endocrinol Metab; 2022 May; 35(5):687-690. PubMed ID: 35119230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine.
    Duarte LF; Gálvez NMS; Iturriaga C; Melo-González F; Soto JA; Schultz BM; Urzúa M; González LA; Vázquez Y; Ríos M; Berríos-Rojas RV; Rivera-Pérez D; Moreno-Tapia D; Pacheco GA; Vallejos OP; Hoppe-Elsholz G; Navarrete MS; Rojas Á; Fasce RA; Fernández J; Mora J; Ramírez E; Zeng G; Meng W; González-Aramundiz JV; González PA; Abarca K; Bueno SM; Kalergis AM
    Front Immunol; 2021; 12():742914. PubMed ID: 34659237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary apoplexy and COVID-19 vaccination: a case report and literature review.
    Aliberti L; Gagliardi I; Rizzo R; Bortolotti D; Schiuma G; Franceschetti P; Gafà R; Borgatti L; Cavallo MA; Zatelli MC; Ambrosio MR
    Front Endocrinol (Lausanne); 2022; 13():1035482. PubMed ID: 36465651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine?
    Ishay A; Shacham EC
    BMC Endocr Disord; 2023 Feb; 23(1):47. PubMed ID: 36810011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.
    Lui DTW; Lee KK; Lee CH; Lee ACH; Hung IFN; Tan KCB
    Front Public Health; 2021; 9():778964. PubMed ID: 34888290
    [No Abstract]   [Full Text] [Related]  

  • 26. Pilot Findings on SARS-CoV-2 Vaccine-Induced Pituitary Diseases: A Mini Review from Diagnosis to Pathophysiology.
    Taieb A; Mounira EE
    Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
    Jarius S; Bieber N; Haas J; Wildemann B
    J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on anti-rabphilin-3A antibodies in 15 consecutive patients presenting with central diabetes insipidus at a single referral center.
    Arihara Z; Sakurai K; Niitsuma S; Sato R; Yamada S; Inoshita N; Iwata N; Fujisawa H; Watanabe T; Suzuki A; Takahashi K; Sugimura Y
    Sci Rep; 2022 Mar; 12(1):4440. PubMed ID: 35292721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study.
    Luchetti Gentiloni MM; Paci V; Marconi V; Gigli M; Benfaremo D; Sordillo R; Macchini C; Massaccesi L; Perna GP; Offidani AM; Moroncini G
    Front Immunol; 2022; 13():859550. PubMed ID: 35386714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation.
    Yousaf AR; Cortese MM; Taylor AW; Broder KR; Oster ME; Wong JM; Guh AY; McCormick DW; Kamidani S; Schlaudecker EP; Edwards KM; Creech CB; Staat MA; Belay ED; Marquez P; Su JR; Salzman MB; Thompson D; Campbell AP;
    Lancet Child Adolesc Health; 2022 May; 6(5):303-312. PubMed ID: 35216660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-pituitary antibodies as a marker of autoimmunity in pituitary glands.
    Iwama S; Arima H
    Endocr J; 2020 Nov; 67(11):1077-1083. PubMed ID: 33055452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis.
    Takahashi Y; Kameda H; Miya A; Nomoto H; Cho KY; Nakamura A; Nishimura H; Kimura H; Suzuki M; Konno S; Shimizu A; Matsuno Y; Okamoto M; Motegi H; Iwata N; Fujisawa H; Suzuki A; Sugimura Y; Miyoshi H; Atsumi T
    Pituitary; 2022 Apr; 25(2):321-327. PubMed ID: 35088194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An elderly patient with transient diabetes insipidus associated with lymphocytic infundibulo-neurohypophysitis.
    Takahashi M; Otsuka F; Miyoshi T; Ogura T; Makino H
    Endocr J; 1999 Oct; 46(5):741-6. PubMed ID: 10670763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical phenotype of AAV, anti-GBM disease and double-positive patients after SARS-CoV-2 vaccination.
    Li Y; Wang J; Liang S; Zhang Y; Feng Z; Cai G
    Autoimmun Rev; 2024 Apr; 23(4):103521. PubMed ID: 38490282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.
    Hsu CM; Weiner DE; Manley HJ; Aweh GN; Ladik V; Frament J; Miskulin D; Argyropoulos C; Abreo K; Chin A; Gladish R; Salman L; Johnson D; Lacson EK
    Clin J Am Soc Nephrol; 2022 Mar; 17(3):403-413. PubMed ID: 35144972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of Anti-SARS-CoV-2-specific IgG Levels in Breast Milk after Vaccination or COVID-19 Infection.
    Temocin F; Çaycı YT; Seren C; Kuruoglu T; Atilla A; Birinci A; Tanyel E
    Am J Perinatol; 2024 May; 41(S 01):e3085-e3090. PubMed ID: 37846474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.